ifezuntirgene inilparvovec, ifezuntirgene inilparvovec
CT-AMT-130-02
Phase 2 small_molecule active
Quick answer
ifezuntirgene inilparvovec, ifezuntirgene inilparvovec for Huntington’s Disease is a Phase 2 program (small_molecule) at uniQure biopharma B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- uniQure biopharma B.V.
- Indication
- Huntington’s Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active